The podocyte has diverse functions including glomerular filtration, biosynt
hesis and maintenance of the glomerular capillary architecture. It discharg
es these functions by virtue of a unique morphology, an intimate relationsh
ip with the capillary wall, and diverse synthetic and membrane specializati
ons. Despite the complex role that it plays in glomerular function, the cli
nical manifestations of podocyte dysfunction are limited to proteinuria and
renal insufficiency. Recurrent focal segmental glomerulosclerosis (FSGS) i
n renal transplants provides a unique opportunity to study the pathogenesis
of FSGS in human beings, because the patients are monitored carefully to i
dentify the onset of disease, the recurrence is presumed to have the same e
tiology as the primary disease, renal biopsy is a tool to study the pathoge
nesis of the lesion, and therapeutic intervention provides a mechanism to t
est pathogenesis. Pathologic studies have identified a proliferative lesion
of the podocytes as the first sign of recurrent disease. The glomerular le
sions evolve to form segmental glomerular scars with time. These findings a
nd studies in experimental models of FSGS implicate podocyte injury in the
pathogenesis of the recurrent disease. The cellular lesion (similar to the
proliferative lesion of podocytes in recurrent FSGS), seen early in the cou
rse of primary FSGS suggests that the pathogenic sequence in recurrent FSGS
also applies to primary FSGS. A soluble circulating factor that increases
glomerular permeability and correlates with recurrence of FSGS has been ide
ntified in the pretransplant serum of patients with end-stage FSGS, but the
mechanism of podocyte injury by this factor remains speculative. In any ca
se, podocytes in the cellular lesion undergo morphologic changes and lose s
pecialized functions seen in the normal mature cell, and these structural a
nd functional abnormalities cause the permeability changes associated with
proteinuria and destruction of glomerular filtration surface by scarring as
sociated with loss of glomerular function.